FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Urs Nydegger

Research Profile

Anatomy

Chemicals & Drugs

Procedures

Living Beings

Blood Donors

Disorders

Physiology

Co-author Network

Publications

TOP 3
Urs E Nydegger; Lorenz Risch
Selected topics of the 4th international cooperative study group meeting on immune thrombocytopenia revisited.
S Gerald Sandler; Urs E Nydegger
Increased safety leads to less restrictive use of plasma transfusions.
Jean-Francois Lambert; Urs E Nydegger
Geoepidemiology of autoimmune hemolytic anemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Urs Nydegger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Urs E Nydegger; Lorenz Risch
Selected topics of the 4th international cooperative study group meeting on immune thrombocytopenia revisited.
Seminars in hematology 2013;50 Suppl 1():S3-9.
2010: S Gerald Sandler; Urs E Nydegger
Increased safety leads to less restrictive use of plasma transfusions.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2010;43(3):375.
2010: Jean-Francois Lambert; Urs E Nydegger
Geoepidemiology of autoimmune hemolytic anemia.
Autoimmunity reviews 2010;9(5):A350-4.
2007: Urs E Nydegger
Immune complex pathophysiology.
Annals of the New York Academy of Sciences 2007;1109():66-83.
2007: Matthias Siepe; Marie Noelle Giraud; Elisabeth Liljensten; Urs E Nydegger; Philippe Menasche; Thierry Carrel; Hendrik T Tevaearai
Construction of skeletal myoblast-based polyurethane scaffolds for myocardial repair.
Artificial organs 2007;31(6):425-33.
2007: Urs E Nydegger; G F Riedler; Willy A Flegel
Histoblood groups other than HLA in organ transplantation.
Transplantation proceedings 2007;39(1):64-8.
2006: Urs E Nydegger; Erich Gygax; Thierry Carrel
Point-of-care testing in the cardiovascular operating theatre.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2006;44(9):1060-5.
2005: Urs E Nydegger; Hendrik T Tevaearai; Pascal A Berdat; Robert Rieben; Thierry Carrel; Paul Mohacsi; Willy A Flegel
Histo-blood group antigens as allo- and autoantigens.
Annals of the New York Academy of Sciences 2005;1050():40-51.
2005: François Achermann; F Julmy; L G Gilliver; Thierry P Carrel; Urs E Nydegger
Soluble type A substance in fresh-frozen plasma as a function of ABO and Secretor genotypes and Lewis phenotype.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2005;32(3):255-62.
2005: Urs E Nydegger; Paul Mohacsi; Simon C Koestner; Andreas Kappeler; Thomas Schaffner; Thierry Carrel
ABO histo-blood group system-incompatible allografting.
International immunopharmacology 2005;5(1):147-53.
2004: Urs E Nydegger; Volkhard Goeber
Specific aspects of transfusion therapy in cardiovascular surgery.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2004;31(1):37-8.
2004: Urs E Nydegger; Robert Rieben; Thierry Carrel; Paul Mohacsi
Solid organ transplantation across the ABO histo-blood group barrier: a case report.
Transplantation proceedings 2004;36(5):1554-7.
2004: Pascal A Berdat; Evelyne Eichenberger; Julia Ebell; Jean-Pierre Pfammatter; Mladen Pavlovic; Claudia Zobrist; Erich Gygax; Urs E Nydegger; Thierry Carrel
Elimination of proinflammatory cytokines in pediatric cardiac surgery: analysis of ultrafiltration method and filter type.
The Journal of thoracic and cardiovascular surgery 2004;127(6):1688-96.
2004: Simon C Koestner; Andreas Kappeler; Thomas Schaffner; Thierry P Carrel; Urs E Nydegger; Paul Mohacsi
Histo-blood group type change of the graft from B to O after ABO mismatched heart transplantation.
Lancet 2004;363(9420):1523-5.
2004: Urs E Nydegger
Intravenous immunoglobulins: too many indications?
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5 Suppl 3():S179-82.
2003: Pascal A Berdat; Thomas J Wehrle; Angelika Küng; François Achermann; Martin Sutter; Thierry P Carrel; Urs E Nydegger
Age-specific analysis of normal cytokine levels in healthy infants.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(10):1335-9.
2003: Friedgard Julmy; François Achermann; Thomas Schulzki; Thierry Carrel; Urs E Nydegger
PLTs of blood group A1 donors express increased surface A antigen owing to apheresis and prolonged storage.
Transfusion 2003;43(10):1378-85.
2003: Beat Kipfer; Lars Englberger; Erich Gygax; Urs E Nydegger; Thierry Carrel
Is reduced systemic heparinization justified with heparin-bonded bypass circuits in cardiac surgery?--Experience with and without aprotinin.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2003;29(1):17-24.
2003: Urs E Nydegger; Walter A Wuillemin; F Julmy; Beat J Meyer; Thierry P Carrel
Association of ABO histo-blood group B allele with myocardial infarction.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2003;30(3):201-6.
2002: Caroline Tinguely; Monica Schaller; Thierry Carrel; Urs E Nydegger
Spectrotype analysis and clonal characteristics of human anti-Gal alpha1-3Gal antibodies.
Xenotransplantation 2002;9(4):252-9.
2002: Lars Englberger; Beat Kipfer; Pascal A Berdat; Urs E Nydegger; Thierry P Carrel
Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?
The Annals of thoracic surgery 2002;73(6):1897-904.
2002: Urs E Nydegger; T Carrel; T Laumonier; Paul Mohacsi
New concepts in organ preservation.
Transplant immunology 2002;9(2-4):215-25.
2001: Paul Mohacsi; Robert Rieben; G Sigurdsson; Hans-Ueli Tschanz; Thomas Schaffner; Urs E Nydegger; Thierry Carrel
Successful management of a B-type cardiac allograft into an O-type man with 3(1/2)-year clinical follow-up.
Transplantation 2001;72(7):1328-30.
2001: Caroline Tinguely; Monica Schaller; Urs E Nydegger
Mononuclear cells ingest E. coli opsonized by investigational intravenous immunoglobulin preparations in the absence of complement more efficiently than polymorphonuclear phagocytes.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2001;25(1):43-50.
2001: Urs E Nydegger; T Sturzenegger
Treatment of autoimmune disease: synergy between plasma exchange and intravenous immunoglobulins.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 2001;5(3):186-92.
2001: Pascal A Berdat; Erich Gygax; Urs E Nydegger; Thierry Carrel
Short- and long-term mechanical cardiac assistance.
The International journal of artificial organs 2001;24(5):263-73.
2001: Urs E Nydegger; M Moerenhout; Caroline Tinguely; Monica Schaller
Gene usage for naturally occurring antibodies.
Transplantation proceedings 2001;33(3):2339-40.
2001: Paul Mohacsi; Robert Rieben; Urs E Nydegger
Immunosuppression in ABO-incompatible transplantation.
Transplantation proceedings 2001;33(3):2223-4.
2001: B Gerber; Caroline Tinguely; N V Bovin; Robert Rieben; Urs E Nydegger
Differences between synthetic oligosaccharide immunoabsorbents in depletion capacity for xenoreactive anti-Galalpha1-3Gal antibodies from human serum.
Xenotransplantation 2001;8(2):106-14.
2001: Urs E Nydegger; Paul Mohacsi
AB0/O terminology.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2001;24(2):227.
2001: Urs E Nydegger; Robert Rieben; Paul Mohacsi
Current precision of immunological extracorporeal plasma treatment.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2001;24(1):39-47.
2001: M Faeh; SP Hauser; Urs E Nydegger
Transient thrombopoietin peak after liver transplantation for end-stage liver disease.
British journal of haematology 2001;112(2):493-8.
2000: B Chatterjee; Urs E Nydegger; Paul Mohacsi
Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonists.
European journal of heart failure 2000;2(4):393-8.
2000: U Doenz; Urs E Nydegger; A Kueng; Thierry Carrel; Paul Mohacsi
Anti-Galalpha1-3Gal IgM/IgG antibody levels in infants: do they have a clinical relevance in pediatric xenotransplantation?
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000;19(11):1108-13.
2000: Urs E Nydegger; Paul Mohacsi; R Escher; A Morell
Clinical use of intravenous immunoglobulins.
Vox sanguinis 2000;78 Suppl 2():191-5.
1999: Urs E Nydegger; M Sturzenegger
Adverse effects of intravenous immunoglobulin therapy.
Drug safety : an international journal of medical toxicology and drug experience 1999;21(3):171-85.
1999: R Buonomano; Caroline Tinguely; Robert Rieben; Paul Mohacsi; Urs E Nydegger
Quantitation and characterization of anti-Galalpha1-3Gal antibodies in sera of 200 healthy persons.
Xenotransplantation 1999;6(3):173-80.
1999: SP Hauser; M Schaller; Urs E Nydegger
Quality assurance in thrombapheresis.
Transfusion science 1999;20(1):73-7.
1998: R S Briellmann; Urs E Nydegger; Matthias Sturzenegger; L Fierz; Christian W Hess; SP Hauser
Long-term treatment of chronic relapsing inflammatory demyelinating polyradiculoneuropathy: combination of corticosteroids, plasma exchange, and intravenous immunoglobulins.
European neurology 1998;39(3):190-1.
1998: E Uetz-von Allmen; Matthias Sturzenegger; Robert Rieben; Frank Rihs; A Frauenfelder; Urs E Nydegger
Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.
European neurology 1998;39(2):103-10.
1998: Y Hari; E C von Allmen; G M Boss; A Naiem; M Gittermann; Urs E Nydegger
The complement-activating capacity of maternal IgG antibodies to blood group A in paired mother/child serum samples.
Vox sanguinis 1998;74(2):95-100.
1997: R Stampfli; M Schaller; T Schenker; M Frey-Wettstein; SP Hauser; Urs E Nydegger
In-process cell counts during preparation of platelet concentrates from buffy coats.
Transfusion science 1997;18(4):495-503.
1997: S Brunner-Bolliger; V Kiefel; F F Horber; Urs E Nydegger; P Berchtold
Antibody studies in a patient with acute thrombocytopenia following infusion of plasma containing anti-PI(A1).
American journal of hematology 1997;56(2):119-21.
1997: Urs E Nydegger
Sepsis and polyspecific intravenous immunoglobulins.
Journal of clinical apheresis 1997;12(2):93-9.
1996: B Walpoth; B Galliker; P Spirig; André Haeberli; A Rosenmund; U Althaus; Urs E Nydegger
Use of epoetin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery.
Seminars in hematology 1996;33(2 Suppl 2):75-6; discussion 77.
1996: Robert Rieben; A Frauenfelder; Urs E Nydegger
Spectrotype analysis of human ABO antibodies: evidence for different clonal heterogeneity of IgM, IgG, and IgA antibody populations.
Vox sanguinis 1996;70(2):104-11.
1995: Robert Rieben; Elena Y Korchagina; E von Allmen; J K Hovinga; B Lammle; Thomas W Jungi; Nicolai V Bovin; Urs E Nydegger
In vitro evaluation of the efficacy and biocompatibility of new, synthetic ABO immunoabsorbents.
Transplantation 1995;60(5):425-30.
1994: E von Allmen; Robert Rieben; Urs E Nydegger
Development of a C1q-ABO-ELISA to measure C1q binding by human anti-A alloantibodies.
Journal of immunological methods 1994;171(1):85-92.
1994: Kurt Leibundgut; J Muff; Andreas Hirt; H Mitschulat; Urs E Nydegger; Annette Ridolfi Lüthy; Andreas Tobler; HP Wagner
Evaluation of the Fresenius cell separator AS 104 for harvesting peripheral blood stem cells in pediatric patients.
Transfusion science 1994;15(1):93-9.
1994: Urs E Nydegger; Robert Rieben
Combined use of plasma exchange and intravenous immunoglobulins.
Annales de médecine interne 1994;145(5):287-92.
1993: Beat H Walpoth; J Schwaller; H Hofstetter; D Castelli; Urs E Nydegger
Current problems with autologous blood supply.
Infusionstherapie und Transfusionsmedizin 1993;20(6):316-26.
1993: C Auf der Maur; M Hodel; Urs E Nydegger; Robert Rieben
Age dependency of ABO histo-blood group antibodies: reexamination of an old dogma.
Transfusion 1993;33(11):915-8.
1992: Robert Rieben; A Tucci; Urs E Nydegger; Rudolf H Zubler
Self tolerance to human A and B histo-blood group antigens exists at the B cell level and cannot be broken by potent polyclonal B cell activation in vitro.
European journal of immunology 1992;22(10):2713-7.
1992: Robert Rieben; A Frauenfelder; Urs E Nydegger
Naturally occurring ABO antibodies: long-term stable, individually distinct anti-A IgG spectrotypes.
European journal of immunology 1992;22(8):2129-33.
1992: Urs E Nydegger
Immunoglobulins in antibacterial defense.
Current studies in hematology and blood transfusion 1992;(59):146-62.
1992: I C Rittmeyer; Urs E Nydegger
Influence of the cryoprotective agents glycerol and hydroxyethyl starch on red blood cell ATP and 2,3-diphosphoglyceric acid levels.
Vox sanguinis 1992;62(3):141-5.
1992: Urs E Nydegger
Cold agglutinin disease.
Annales de médecine interne 1992;143(6):361-4.
1991: Robert Rieben; J P Buchs; E Flückiger; Urs E Nydegger
Antibodies to histo-blood group substances A and B: agglutination titers, Ig class, and IgG subclasses in healthy persons of different age categories.
Transfusion 1991;31(7):607-15.
1991: J P Buchs; Urs E Nydegger
Defining the specificity of anti-A/B IgM/G antibodies with different antigens and lectins.
Vox sanguinis 1991;60(3):174-80.
1991: Urs E Nydegger; M D Kazatchkine; P A Miescher
Immunopathologic and clinical features of hemolytic anemia due to cold agglutinins.
Seminars in hematology 1991;28(1):66-77.
1990: Thomas W Jungi; Marija Brcic; P Kuhnert; M O Spycher; F Li; Urs E Nydegger
Effect of IgG for intravenous use on Fc receptor-mediated phagocytosis by human monocytes.
Clinical and experimental immunology 1990;82(1):163-9.
1990: L Borradori; D Castelli; E Flueckiger; Urs E Nydegger
Clinical significance of platelet-associated immunoglobulins in narcotic addicts with human immunodeficiency virus infection.
Clinical immunology and immunopathology 1990;54(2):256-65.
1990: Urs E Nydegger; Robert Rieben; B Aeschbacher
Biocompatibility of apheresis harness.
Transfusion science 1990;11(1):43-54.
1990: Thomas W Jungi; Urs E Nydegger
Plasma exchange and intravenous immunoglobulin infusion: antagonistic effects on mononuclear phagocyte functions with potential implications for therapy.
Progress in clinical and biological research 1990;337():429-33.
1990: Urs E Nydegger; Robert Rieben; Thomas W Jungi
Synergy between plasma exchange and intravenous immunoglobulin.
Current studies in hematology and blood transfusion 1990;(57):31-50.
1989: Urs E Nydegger; J P Buchs; L Borradori
Relative importance of total versus external platelet-associated IgG.
Blut 1989;59(1):67-74.
1989: J P Buchs; Urs E Nydegger
Development of an ABO-ELISA for the quantitation of human blood group anti-A and anti-B IgM and IgG antibodies.
Journal of immunological methods 1989;118(1):37-46.
1989: B Aeschbacher; André Haeberli; Urs E Nydegger
Donor safety and plasma quality in automated plasmapheresis. Comparison of two filter materials.
Vox sanguinis 1989;57(2):104-11.
1987: Urs E Nydegger; P Vaudaux; D Castelli
Trends in clinical hemapheresis 1986. Progress report on the 4th annual meeting of the European Society for Hemapheresis.
Infusionstherapie und klinische Ernährung 1987;14 Suppl 4():4-6.
1987: Urs E Nydegger
Choice of replacement fluid for plasma exchange.
Life support systems : the journal of the European Society for Artificial Organs 1987;5(3):279-82.